Analysts are on the Bearish side about MAXIMUS, Inc. (NYSE:MMS) this week.

June 15, 2018 - By Dolores Ford

MAXIMUS, Inc. (NYSE:MMS) LogoInvestors sentiment increased to 1.32 in Q1 2018. Its up 0.22, from 1.1 in 2017Q4. It increased, as 29 investors sold MAXIMUS, Inc. shares while 86 reduced holdings. 50 funds opened positions while 102 raised stakes. 59.08 million shares or 1.74% more from 58.07 million shares in 2017Q4 were reported.
Renaissance Lc, a New York-based fund reported 218,590 shares. Rice Hall James & Associate Ltd Liability holds 349,562 shares. Vident Advisory Ltd Liability reported 2,976 shares. Bridgeway Cap Mgmt Inc has invested 0.01% of its portfolio in MAXIMUS, Inc. (NYSE:MMS). Old Mutual (Uk) Limited, a United Kingdom-based fund reported 96,936 shares. Shelton Cap Mngmt accumulated 0.02% or 4,622 shares. Parkside Fin Commercial Bank has invested 0.03% in MAXIMUS, Inc. (NYSE:MMS). Asset Mngmt One invested in 0% or 12,800 shares. Zebra Capital Management Limited Company holds 0.1% or 4,075 shares in its portfolio. Alphaone Inv Svcs Lc reported 0.01% stake. Verus Fincl Incorporated reported 0.23% stake. Canada Pension Plan Investment Board, a Ontario – Canada-based fund reported 75,300 shares. Clearbridge Invests Ltd accumulated 749,134 shares. Meeder Asset Mngmt holds 0.01% or 1,612 shares. The Maryland-based Campbell & Adviser Limited Liability Corp has invested 0.17% in MAXIMUS, Inc. (NYSE:MMS).

Since February 13, 2018, it had 0 insider buys, and 3 insider sales for $2.34 million activity. MONTONI RICHARD A had sold 30,000 shares worth $2.04 million on Tuesday, February 20. $66,550 worth of MAXIMUS, Inc. (NYSE:MMS) was sold by BELIVEAU RUSSELL A on Monday, April 2.

MAXIMUS, Inc. (NYSE:MMS) Ratings Coverage

Among 5 analysts covering Maximus (NYSE:MMS), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Maximus had 6 analyst reports since January 3, 2018 according to SRatingsIntel. The stock of MAXIMUS, Inc. (NYSE:MMS) earned “Buy” rating by First Analysis on Tuesday, May 8. The rating was maintained by Canaccord Genuity with “Hold” on Friday, February 9. The firm has “Hold” rating by Canaccord Genuity given on Friday, May 11. The firm earned “Hold” rating on Wednesday, January 3 by Robert W. Baird. As per Thursday, February 8, the company rating was maintained by Jefferies. The firm earned “Hold” rating on Friday, February 9 by Maxim Group. Below is a list of MAXIMUS, Inc. (NYSE:MMS) latest ratings and price target changes.

11/05/2018 Broker: Canaccord Genuity Old Rating: Hold New Rating: Hold Old Target: $65 New Target: $64 Maintain
08/05/2018 Broker: First Analysis Rating: Buy New Target: $81.0000 Upgrade
09/02/2018 Broker: Canaccord Genuity Old Rating: Hold New Rating: Hold Old Target: $71 New Target: $65 Maintain
09/02/2018 Broker: Maxim Group Old Rating: Buy New Rating: Hold Old Target: $66 New Target: $69 Maintain
08/02/2018 Broker: Jefferies Rating: Hold New Target: $65.0 Maintain
03/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $75.0 Maintain

The stock decreased 0.54% or $0.34 during the last trading session, reaching $62.13. About 142,602 shares traded. MAXIMUS, Inc. (NYSE:MMS) has declined 1.35% since June 15, 2017 and is downtrending. It has underperformed by 13.92% the S&P500.

MAXIMUS, Inc. provides business process services to government health and human services programs in the United States, the United Kingdom, Australia, Canada, and Saudi Arabia. The company has market cap of $4.05 billion. The companyÂ’s Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Fit for Work Service. It has a 18.27 P/E ratio. The Company’s services include health insurance exchange customer contact center activities and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; health plan oversight; eHealth solutions with the Medigent product suite; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services.

MAXIMUS, Inc. (NYSE:MMS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: